Literature DB >> 23884437

Disease-specific perception of fracture risk and incident fracture rates: GLOW cohort study.

C L Gregson1, E M Dennison, J E Compston, S Adami, J D Adachi, F A Anderson, S Boonen, R Chapurlat, A Díez-Pérez, S L Greenspan, F H Hooven, A Z LaCroix, J W Nieves, J C Netelenbos, J Pfeilschifter, M Rossini, C Roux, K G Saag, S Silverman, E S Siris, N B Watts, A Wyman, C Cooper.   

Abstract

UNLABELLED: Accurate patient risk perception of adverse health events promotes greater autonomy over, and motivation towards, health-related lifestyles.
INTRODUCTION: We compared self-perceived fracture risk and 3-year incident fracture rates in postmenopausal women with a range of morbidities in the Global Longitudinal study of Osteoporosis in Women (GLOW).
METHODS: GLOW is an international cohort study involving 723 physician practices across ten countries (Europe, North America, Australasia); 60,393 women aged ≥55 years completed baseline questionnaires detailing medical history and self-perceived fracture risk. Annual follow-up determined self-reported incident fractures.
RESULTS: In total 2,945/43,832 (6.8%) sustained an incident fracture over 3 years. All morbidities were associated with increased fracture rates, particularly Parkinson's disease (hazard ratio [HR]; 95% confidence interval [CI], 3.89; 2.78-5.44), multiple sclerosis (2.70; 1.90-3.83), cerebrovascular events (2.02; 1.67-2.46), and rheumatoid arthritis (2.15; 1.53-3.04) (all p < 0.001). Most individuals perceived their fracture risk as similar to (46%) or lower than (36%) women of the same age. While increased self-perceived fracture risk was strongly associated with incident fracture rates, only 29% experiencing a fracture perceived their risk as increased. Under-appreciation of fracture risk occurred for all morbidities, including neurological disease, where women with low self-perceived fracture risk had a fracture HR 2.39 (CI 1.74-3.29) compared with women without morbidities.
CONCLUSIONS: Postmenopausal women with morbidities tend to under-appreciate their risk, including in the context of neurological diseases, where fracture rates were highest in this cohort. This has important implications for health education, particularly among women with Parkinson's disease, multiple sclerosis, or cerebrovascular disease.

Entities:  

Mesh:

Year:  2013        PMID: 23884437      PMCID: PMC3867337          DOI: 10.1007/s00198-013-2438-y

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  44 in total

Review 1.  The prevalence of multiple sclerosis in the world: an update.

Authors:  G Rosati
Journal:  Neurol Sci       Date:  2001-04       Impact factor: 3.307

Review 2.  Clinical review. Risk factors for low bone mass-related fractures in men: a systematic review and meta-analysis.

Authors:  Matthew T Drake; Mohammad Hassan Murad; Karen F Mauck; Melanie A Lane; Chaitanya Undavalli; Tarig Elraiyah; Louise M Stuart; Chaithra Prasad; Anas Shahrour; Rebecca J Mullan; Ahmad Hazem; Patricia J Erwin; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2012-03-30       Impact factor: 5.958

3.  Women with cardiovascular disease have increased risk of osteoporotic fracture.

Authors:  Jian Sheng Chen; Chris Hogan; Greg Lyubomirsky; Philip N Sambrook
Journal:  Calcif Tissue Int       Date:  2010-11-04       Impact factor: 4.333

4.  Improving the interface between primary and secondary care: a statement from the European Working Party on Quality in Family Practice (EQuiP).

Authors:  O J Kvamme; F Olesen; M Samuelson; M Samuelsson
Journal:  Qual Health Care       Date:  2001-03

5.  Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology.

Authors:  T A Zesiewicz; K L Sullivan; I Arnulf; K R Chaudhuri; J C Morgan; G S Gronseth; J Miyasaki; D J Iverson; W J Weiner
Journal:  Neurology       Date:  2010-03-16       Impact factor: 9.910

Review 6.  Severity of osteoporosis: what is the impact of co-morbidities?

Authors:  Claire David; Cyrille B Confavreux; Nadia Mehsen; Julien Paccou; Ariane Leboime; Erick Legrand
Journal:  Joint Bone Spine       Date:  2010-12       Impact factor: 4.929

7.  Effect of co-morbidities on fracture risk: findings from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

Authors:  Elaine M Dennison; Juliet E Compston; Julie Flahive; Ethel S Siris; Stephen H Gehlbach; Jonathan D Adachi; Steven Boonen; Roland Chapurlat; Adolfo Díez-Pérez; Frederick A Anderson; Frederick H Hooven; Andrea Z LaCroix; Robert Lindsay; J Coen Netelenbos; Johannes Pfeilschifter; Maurizio Rossini; Christian Roux; Kenneth G Saag; Philip Sambrook; Stuart Silverman; Nelson B Watts; Susan L Greenspan; Melissa Premaor; Cyrus Cooper
Journal:  Bone       Date:  2012-03-09       Impact factor: 4.398

8.  Risk of fractures in patients with multiple sclerosis: a population-based cohort study.

Authors:  M T Bazelier; T-P van Staa; B M J Uitdehaag; C Cooper; H G M Leufkens; P Vestergaard; R M C Herings; F de Vries
Journal:  Neurology       Date:  2012-05-16       Impact factor: 9.910

Review 9.  Guidelines for the management of inflammatory bowel disease in adults.

Authors:  Craig Mowat; Andrew Cole; Al Windsor; Tariq Ahmad; Ian Arnott; Richard Driscoll; Sally Mitton; Tim Orchard; Matt Rutter; Lisa Younge; Charlie Lees; Gwo-Tzer Ho; Jack Satsangi; Stuart Bloom
Journal:  Gut       Date:  2011-05       Impact factor: 23.059

10.  Failure to perceive increased risk of fracture in women 55 years and older: the Global Longitudinal Study of Osteoporosis in Women (GLOW).

Authors:  E S Siris; S Gehlbach; J D Adachi; S Boonen; R D Chapurlat; J E Compston; C Cooper; P Delmas; A Díez-Pérez; F H Hooven; A Z Lacroix; J C Netelenbos; J Pfeilschifter; M Rossini; C Roux; K G Saag; P Sambrook; S Silverman; N B Watts; A Wyman; S L Greenspan
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

View more
  28 in total

1.  The Relationship of Perceived Risk and Biases in Perceived Risk to Fracture Prevention Behavior in Older Women.

Authors:  Salene M W Jones; Nancy M Gell; Joshua A Roth; Delia Scholes; Andrea Z LaCroix
Journal:  Ann Behav Med       Date:  2015-10

Review 2.  Insights from the Global Longitudinal Study of Osteoporosis in Women (GLOW).

Authors:  Nelson B Watts
Journal:  Nat Rev Endocrinol       Date:  2014-04-22       Impact factor: 43.330

3.  The association between multiple sclerosis and fracture risk.

Authors:  Shile Su; Hao Liu
Journal:  Int J Clin Exp Med       Date:  2014-11-15

4.  Risk and outcomes of fracture in peripheral arterial disease patients: two nationwide cohort studies.

Authors:  F-L Liu; C-S Lin; C-C Yeh; C-C Shih; Y-G Cherng; C-H Wu; T-L Chen; C-C Liao
Journal:  Osteoporos Int       Date:  2017-08-18       Impact factor: 4.507

5.  Self-perception of fracture risk: what can it tell us?

Authors:  A E Litwic; J E Compston; A Wyman; E S Siris; S H Gehlbach; J D Adachi; R Chapurlat; A Díez-Pérez; A Z LaCroix; J W Nieves; J C Netelenbos; J Pfeilschifter; M Rossini; C Roux; K G Saag; S Silverman; N B Watts; S L Greenspan; L March; C L Gregson; C Cooper; E M Dennison
Journal:  Osteoporos Int       Date:  2017-08-31       Impact factor: 4.507

6.  The safety and effectiveness profile of eldecalcitol in a prospective, post-marketing observational study in Japanese patients with osteoporosis: interim report.

Authors:  Hitoshi Saito; Hiroyuki Kakihata; Yosuke Nishida; Sawako Yatomi; Shigeru Nihojima; Yumiko Kobayashi; Hidehiro Tabata; Makoto Nomura
Journal:  J Bone Miner Metab       Date:  2016-10-03       Impact factor: 2.626

7.  Incidence of fractures among patients with rheumatoid arthritis: a systematic review and meta-analysis.

Authors:  S Jin; E Hsieh; L Peng; C Yu; Y Wang; C Wu; Q Wang; M Li; X Zeng
Journal:  Osteoporos Int       Date:  2018-03-15       Impact factor: 4.507

Review 8.  Risk Factors, Epidemiology and Treatment Strategies for Metabolic Bone Disease in Patients with Neurological Disease.

Authors:  S Binks; R Dobson
Journal:  Curr Osteoporos Rep       Date:  2016-10       Impact factor: 5.096

9.  Evaluation of a Multimodal, Direct-to-Patient Educational Intervention Targeting Barriers to Osteoporosis Care: A Randomized Clinical Trial.

Authors:  Maria I Danila; Ryan C Outman; Elizabeth J Rahn; Amy S Mudano; David T Redden; Peng Li; Jeroan J Allison; Fred A Anderson; Allison Wyman; Susan L Greenspan; Andrea Z LaCroix; Jeri W Nieves; Stuart L Silverman; Ethel S Siris; Nelson B Watts; Michael J Miller; Jeffrey R Curtis; Amy H Warriner; Nicole C Wright; Kenneth G Saag
Journal:  J Bone Miner Res       Date:  2018-02-26       Impact factor: 6.741

Review 10.  The impact of fragility fracture and approaches to osteoporosis risk assessment worldwide.

Authors:  Elizabeth M Curtis; Rebecca J Moon; Nicholas C Harvey; Cyrus Cooper
Journal:  Bone       Date:  2017-01-22       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.